Islet cell allotransplantation as a model system for a bioengineering approach to reparative medicine: immunological concerns.
Harlan
David M
DM
National Institute of Diabetes, Digestive and Kidney Diseases/NIH, Building 10, Room 11S210, 10 Center Drive, Bethesda, MD 20892, USA. davidmh@intra.niddk.nih.gov
D000818:Animals; D001698:Biomedical Engineering / Q000379:methods*; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy; D007107:Immune System / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007515:Islets of Langerhans / Q000166:cytology*; D016381:Islets of Langerhans Transplantation / Q000009:adverse effects / Q000379:methods*; D008253:Macaca mulatta; D013997:Time Factors; D014945:Wound Healing
D007166:Immunosuppressive Agents